口服葡萄糖耐量试验中1小时血糖升高的意义研究进展

doi:10.12114/j.issn.1007-9572.2022.0311

中国全科医学 ›› 2022, Vol. 25 ›› Issue (35): 4468-4472.DOI: 10.12114/j.issn.1007-9572.2022.0311

口服葡萄糖耐量试验中1小时血糖升高的意义研究进展

黄雨澄¹^,², 董爱梅¹^,²^,³^,^*(), 黄有媛³, 费秀文¹^,²

¹100034　北京市，北京大学第一医院全科医学科
²100034　北京市，北京大学医学部全科医学学系
³100034　北京市，北京大学第一医院内分泌科

收稿日期:2022-03-13 修回日期:2022-05-10 出版日期:2022-12-15 发布日期:2022-06-16
通讯作者: 董爱梅
黄雨澄，董爱梅，黄有媛，等.口服葡萄糖耐量试验中1小时血糖升高的意义研究进展[J].中国全科医学，2022，25（35）：4468-4472. [www.chinagp.net]
作者贡献：黄雨澄、董爱梅提出综述撰写思路；黄雨澄负责文献搜索、文献阅读，论文起草、撰写；董爱梅、黄有媛、费秀文负责文章修改；董爱梅负责最终版本修订，对论文负责。
基金资助:
2020年度北京大学临床医学+X青年专项资助项目--探索胰岛β细胞数量及功能在体无创评价方法(PKU2020LCXQ026)

A Review on the Significance of Elevated 1-hour Post-load Plasma Glucose during the Oral Glucose Tolerance Test

HUANG Yucheng¹^,², DONG Aimei¹^,²^,³^,^*(), HUANG Youyuan³, FEI Xiuwen¹^,²

¹Department of General Practice, Peking University First Hospital, Beijing 100034, China
²School of General Practice, Peking University Health Science Center, Beijing 100034, China
³Department of Endocrinology, Peking University First Hospital, Beijing 100034, China

Received:2022-03-13 Revised:2022-05-10 Published:2022-12-15 Online:2022-06-16
Contact: DONG Aimei
About author:
HUANG Y C, DONG A M, HUANG Y Y, et al. A review on the significance of elevated 1-hour post-load plasma glucose during the oral glucose tolerance test[J]. Chinese General Practice, 2022, 25 (35) : 4468-4472.

分享到

摘要/Abstract

摘要： 口服葡萄糖耐量试验（OGTT）1 h血糖升高可能伴随胰岛素抵抗与胰岛β细胞功能障碍，与糖尿病及心血管疾病发生风险有关。本文综述了OGTT 1 h血糖升高的意义，相关研究显示10%~40%的糖耐量正常人群出现1 h血糖升高，在糖耐量受损（IGT）或空腹血糖受损（IFG）人群中比例更高。因此，临床应关注OGTT 1 h血糖，并在中国人群中明确用于糖尿病和糖尿病前期诊断的可能切点，将有助于早期诊断与干预。

关键词: 糖尿病，2型, 葡糖耐量试验, 葡糖耐受不良, 餐后1小时血糖, 糖尿病前期

Abstract:

Elevated 1-hour post-load plasma glucose (1 hPG) concentration during the oral glucose tolerance test (OGTT) may be associated with insulin resistance and pancreatic β-cell dysfunction, and higher risks of diabetes and cardiovascular disease. We reviewed the studies related to the significance of 1 hPG during the OGTT, in which 1 hPG during the OGTT has been reported to be prevalent in 10% to 40% of people with normal glucose tolerance, and the prevalence is higher in those with impaired glucose tolerance or impaired fasting glucose. Attention should be paid to the cutoff point of 1 hPG during the OGTT for the diagnosis of diabetes and pre-diabetes in Chinese population, which may be beneficial to early diagnosis and intervention of diabetes and pr-diabetes.

Key words: Diabetes mellitus, type 2, Glucose tolerance test, Glucose intolerance, 1-hour post-load plasma glucose, Prediabetic state

黄雨澄,董爱梅,黄有媛,等. 口服葡萄糖耐量试验中1小时血糖升高的意义研究进展[J]. 中国全科医学, 2022, 25(35): 4468-4472. DOI: 10.12114/j.issn.1007-9572.2022.0311.
HUANG Yucheng,DONG Aimei,HUANG Youyuan, et al. A Review on the Significance of Elevated 1-hour Post-load Plasma Glucose during the Oral Glucose Tolerance Test[J]. Chinese General Practice, 2022, 25(35): 4468-4472. DOI: 10.12114/j.issn.1007-9572.2022.0311.

参考文献 31

[1]	OGURTSOVA K，GUARIGUATA L，BARENGO N C，et al. IDF diabetes Atlas：global estimates of undiagnosed diabetes in adults for 2021[J]. Diabetes Res Clin Pract，2022，183：109118. DOI：10.1016/j.diabres.2021.109118.
[2]	UNWIN N，SHAW J，ZIMMET P，et al. Impaired glucose tolerance and impaired fasting glycaemia：the current status on definition and intervention[J]. Diabet Med，2002，19（9）：708-723. DOI：10.1046/j.1464-5491.2002.00835.x.
[3]	LI Y Z，TENG D，SHI X G，et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association：national cross sectional study[J]. BMJ，2020，369：m997. DOI：10.1136/bmj.m997.
[4]	ABDUL-GHANI M A，WILLIAMS K，DEFRONZO R，et al. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose[J]. Diabetes Care，2006，29（7）：1613-1618. DOI：10.2337/dc05-1711.
[5]	BERGMAN M，MANCO M，SESTI G，et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl （8.6 mmol/L）[J]. Diabetes Res Clin Pract，2018，146：18-33. DOI：10.1016/j.diabres.2018.09.017.
[6]	FIORENTINO T V，MARINI M A，SUCCURRO E，et al. One-hour postload hyperglycemia：implications for prediction and prevention of type 2 diabetes[J]. J Clin Endocrinol Metab，2018，103（9）：3131-3143. DOI：10.1210/jc.2018-00468.
[7]	ABDUL-GHANI M A，ABDUL-GHANI T，ALI N，et al. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes[J]. Diabetes Care，2008，31（8）：1650-1655. DOI：10.2337/dc08-0225.
[8]	ABDUL-GHANI M A，LYSSENKO V，TUOMI T，et al. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes：results from the Botnia Study[J]. Diabetes Care，2009，32（2）：281-286. DOI：10.2337/dc08-1264.
[9]	FIORENTINO T V，SESTI F，ANDREOZZI F，et al. Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions[J]. Nutr Metab Cardiovasc Dis，2016，26（5）：439-441. DOI：10.1016/j.numecd.2016.01.009.
[10]	FIORENTINO T V，SESTI F，ANDREOZZI F，et al. One-hour post-load hyperglycemia combined with HbA_1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden[J]. Atherosclerosis，2016，253：61-69. DOI：10.1016/j.atherosclerosis.2016.08.020.
[11]	PRIYA M，ANJANA R M，CHIWANGA F S，et al. 1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians[J]. Diabetes Technol Ther，2013，15（6）：497-502. DOI：10.1089/dia.2013.0025.
[12]	ZHOU W B，GU Y Y，LI H，et al. Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test[J]. Eur J Endocrinol，2006，155（1）：191-197. DOI：10.1530/eje.1.02188.
[13]	TABáK A G，JOKELA M，AKBARALY T N，et al. Trajectories of glycaemia，insulin sensitivity，and insulin secretion before diagnosis of type 2 diabetes：an analysis from the Whitehall II study[J]. Lancet，2009，373（9682）：2215-2221. DOI：10.1016/S0140-6736(09)60619-X.
[14]	MARINI M A，SUCCURRO E，FRONTONI S，et al. Insulin sensitivity，β-cell function，and incretin effect in individuals with elevated 1-hour postload plasma glucose levels[J]. Diabetes Care，2012，35（4）：868-872. DOI：10.2337/dc11-2181.
[15]	PADDOCK E，HOHENADEL M G，PIAGGI P，et al. One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans[J]. Diabetologia，2017，60（9）：1704-1711. DOI：10.1007/s00125-017-4332-1.
[16]	VILCHIS-FLORES L H，BARAJAS-MEDINA G A，VILLA-MARTíNEZ A K，et al. Pancreatic β-cell dysfunction in normoglycemic patients and risk factors[J]. Acta Diabetol，2019，56（12）：1305-1314. DOI：10.1007/s00592-019-01411-9.
[17]	MANCO M，PANUNZI S，MACFARLANE D P，et al. One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance：cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk （RISC） study[J]. Diabetes Care，2010，33（9）：2090-2097. DOI：10.2337/dc09-2261.
[18]	ABDUL-GHANI M A，WILLIAMS K，DEFRONZO R A，et al. What is the best predictor of future type 2 diabetes? [J]. Diabetes Care，2007，30（6）：1544-1548. DOI：10.2337/dc06-1331.
[19]	RONG L J，LUO N，GONG Y P，et al. One-hour plasma glucose concentration can identify elderly Chinese male subjects at high risk for future type 2 diabetes mellitus：a 20-year retrospective and prospective study[J]. Diabetes Res Clin Pract，2021，173：108683. DOI：10.1016/j.diabres.2021.108683.
[20]	FIORENTINO T V，MARINI M A，ANDREOZZI F，et al. One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose[J]. J Clin Endocrinol Metab，2015，100（10）：3744-3751. DOI：10.1210/jc.2015-2573.
[21]	PAREEK M，BHATT D L，NIELSEN M L，et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test：a prospective population-based cohort study[J]. Diabetes Care，2018，41（1）：171-177. DOI：10.2337/dc17-1351.
[22]	American Diabetes Association. 2. Classification and diagnosis of diabetes：standards of medical care in diabetes-2021[J]. Diabetes Care，2021，44（Suppl 1）：S15-33. DOI：10.2337/dc21-S002.
[23]	Diabetes mellitus. Report of a WHO study group[J]. World Health Organ Tech Rep Ser，1985，727：1-113.
[24]	PADDOCK E，LOOKER H C，PIAGGI P，et al. One-hour plasma glucose compared with two-hour plasma glucose in relation to diabetic retinopathy in American indians[J]. Diabetes Care，2018，41（6）：1212-1217. DOI：10.2337/dc17-1900.
[25]	The European Diabetes Epidemiology Group Decode Study Group. Glucose tolerance and cardiovascular mortality：comparison of fasting and 2-hour diagnostic criteria[J]. Arch Intern Med，2001，161（3）：397-405. DOI：10.1001/archinte.161.3.397.
[26]	Glucose tolerance and mortality：comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology：collaborative analysis of diagnostic criteria in Europe[J]. Lancet，1999，354（9179）：617-621.
[27]	BIANCHI C，MICCOLI R，TROMBETTA M，et al. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function，insulin resistance，and worse cardiovascular risk profile：the GENFIEV study[J]. J Clin Endocrinol Metab，2013，98（5）：2100-2105. DOI：10.1210/jc.2012-3971.
[28]	BERGMAN M，CHETRIT A，ROTH J，et al. One-hour post-load plasma glucose level during the OGTT predicts mortality：observations from the Israel Study of Glucose Intolerance，Obesity and Hypertension[J]. Diabet Med，2016，33（8）：1060-1066. DOI：10.1111/dme.13116.
[29]	American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care，2014，37（Suppl 1）：S81-90. DOI：10.2337/dc14-S081.
[30]	MAKAROFF L E. The need for international consensus on prediabetes[J]. Lancet Diabetes Endocrinol，2017，5（1）：5-7. DOI：10.1016/S2213-8587(16)30328-X.
[31]	AHUJA V，ARONEN P，PRAMODKUMAR T A，et al. Erratum. accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults：a meta-analysis[J]. Diabetes Care，2021，44（6）：1457. DOI：10.2337/dc21-er06c.

口服葡萄糖耐量试验中1小时血糖升高的意义研究进展

A Review on the Significance of Elevated 1-hour Post-load Plasma Glucose during the Oral Glucose Tolerance Test

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 31

相关文章 15

编辑推荐

Metrics

留言

[1]	李殿江, 潘恩春, 孙中明, 文进博, 王苗苗, 武鸣, 沈冲. 社区2型糖尿病患者临床惰性现状及其影响因素分析[J]. 中国全科医学, 2023, 26(34): 4296-4301.
[2]	林恺, 姚弥, 陈章, 纪欣鑫, 林润琪, 陈永松, Sim MOIRA. 2型糖尿病治疗负担的概念框架及应对方式：基于视频记录分析[J]. 中国全科医学, 2023, 26(34): 4302-4307.
[3]	周小琦, 刘新会, 张微, 李长风, 严亚琼. 老年人丙氨酸氨基转移酶和天冬氨酸氨基转移酶/丙氨酸氨基转移酶与2型糖尿病及代谢综合征的相关性研究[J]. 中国全科医学, 2023, 26(29): 3645-3649.
[4]	孔德先, 邢煜玲, 孙文文, 张智敏, 周霏, 马慧娟. 预估葡萄糖处理率与2型糖尿病合并代谢相关脂肪性肝病的相关性研究[J]. 中国全科医学, 2023, 26(26): 3252-3258.
[5]	陈伦文, 周阳, 闫国栋, 沈怡, 孙晨, 蔡婉丽, 褚敏捷, 肖静. 2型糖尿病的恶性肿瘤风险：一项基于人群的前瞻性研究[J]. 中国全科医学, 2023, 26(26): 3238-3245.
[6]	费思杰, 张强, 刘方方, 白璐, 孙彩红, 信彩凤. 糖化血红蛋白变异性与2型糖尿病合并射血分数保留心力衰竭患者新发心房颤动的关系研究[J]. 中国全科医学, 2023, 26(26): 3246-3251.
[7]	卢作维, 曹宏伟, 刘涛, 张娜娜, 陈艳艳, 史勤利, 刘向阳, 王琼, 赖敬波, 李晓苗. 2型糖尿病患者微量白蛋白尿进展至大量白蛋白尿的风险预测模型研究[J]. 中国全科医学, 2023, 26(26): 3259-3268.
[8]	赵丽珍, 李卫民, 姜瑞霞. 系统免疫炎症指数对社区老年2型糖尿病患者并发糖尿病肾病的临床诊断价值研究[J]. 中国全科医学, 2023, 26(18): 2227-2231.
[9]	方福生, 刘星宇, 闫双通, 王宁, 李春霖, 田慧. 老年男性2型糖尿病患者目标范围内时间与长期血糖变异性的关系研究[J]. 中国全科医学, 2023, 26(16): 1979-1983.
[10]	张丽娜, 王岩, 张抗怀, 李友佳. 新型降糖药物替西帕肽的临床研究进展[J]. 中国全科医学, 2023, 26(15): 1902-1908.
[11]	杨蓓, 韩琳, 王茵, 程康耀. 持续皮下胰岛素注射治疗老年2型糖尿病效果的Meta分析与试验序贯分析[J]. 中国全科医学, 2023, 26(15): 1892-1901.
[12]	徐迪, 田金萍, 刘赟玥, 薛冷, 张林, 孙国珍, 王连生, 徐晶晶. 冠心病合并2型糖尿病患者经皮冠状动脉介入治疗围术期血糖波动的特点及影响因素研究[J]. 中国全科医学, 2023, 26(15): 1863-1872.
[13]	孟启哲, 奚志, 王铭, 王洋, 杨霄鹏. 2型糖尿病合并近期皮质下小梗死患者血糖变异性与梗死负担及认知功能障碍的相关性研究[J]. 中国全科医学, 2023, 26(15): 1885-1891.
[14]	王海燕, 黄源, 桂春. 2型糖尿病对扩张型心肌病患者预后的影响研究[J]. 中国全科医学, 2023, 26(15): 1840-1846.
[15]	王凌霄, 董荣娜, 周冰, 郭丽娜, 李晶. 人机交互智能管理对初发2型糖尿病患者血糖控制的影响研究[J]. 中国全科医学, 2023, 26(15): 1817-1823.